Add to clipboard
 |  Share  |  Email  |  Print     Updated August 22, 2017
Suggest an Update
Organization: JDRFC Peel-Halton Chapter - Mississauga  
Phone Numbers: 905-608-8067
Toll-Free: 1-877-287-3533
Fax: 905-608-8062
Email: peelhaton@jdrf.ca
Website: www.jdrf.ca
Address:
6620 Kitimat Rd, Unit 1A
Mississauga, ON
L5N 2B8
Intersection: Mississauga Rd and Argentia Rd
Accessibility: Wheelchair Accessible    Wheelchair Accessible
Hours: Mon-Fri 8:30am-4:30pm (Administration)
Executives: Dave Prowten - President and Chief Executive Officer
Nancy Roper - Vice president, Donor Relations
Contacts: Laura Liscio
905-608-8067 ext 221 * lliscio@jdrf.ca
Service Description: Collaborates with Canadian universities and research institutions to find a cure for type 1 diabetes and its complications
  • charitable funder and advocate for type 1 diabetes research
  • improves the lives of people living with the disease
  • provides complimentary Bag of Hope, which contains a variety of educational and reference materials to help newly diagnosed children and families
  • children under the age of 12 also receive a Rufus or Ruby, the Bear with Diabetes™, designed to help children cope and learn about insulin injections children
  • the Mentor Program provides emotional support, information about diabetes resources, education about what families can do to help find a cure
  • the School Advisory Toolkit offers collaborative methods for educators and parents of children with diabetes to ensure that every child enjoys the best possible school experience

Fees: None
Application: Not applicable
Eligibility - Population(s) Served: People of all ages with diabetes
Languages: English ; French
Language Note: French publications and website
Area(s) Served:
Mississauga and area  
See Also: Diabetes
Diabetes Education Programs
Diseases and Conditions Support Groups

This information was last completely updated on August 22, 2017

Suggest an Update

© 2018, Mississauga Halton Local Health Integration Network




About Us
JDRF is a global leader in the search for an end to type 1 diabetes (T1D), through both research funding and advocacy